Cipla Limited

NSEI:CIPLA 주식 보고서

시가총액: ₹1.2t

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cipla 과거 수익 실적

과거 기준 확인 5/6

Cipla은 연평균 18.4%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 수입이 증가했으며, 연간 17%였습니다. 매출은 연평균 9.2%의 비율로 증가했습니다. Cipla의 자기자본이익률은 15.5%이고 순이익률은 16.2%입니다.

주요 정보

18.4%

수익 성장률

18.3%

EPS 성장률

Pharmaceuticals 산업 성장17.5%
매출 성장률9.2%
자기자본 수익률15.5%
순이익16.2%
최근 수익 업데이트31 Mar 2024

최근 과거 실적 업데이트

Recent updates

Cipla (NSE:CIPLA) Is Increasing Its Dividend To ₹13.00

Jun 06
Cipla (NSE:CIPLA) Is Increasing Its Dividend To ₹13.00

Cipla's (NSE:CIPLA) Upcoming Dividend Will Be Larger Than Last Year's

May 21
Cipla's (NSE:CIPLA) Upcoming Dividend Will Be Larger Than Last Year's

Earnings Update: Cipla Limited (NSE:CIPLA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

May 14
Earnings Update: Cipla Limited (NSE:CIPLA) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

May 03
With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Feb 14
Is Cipla (NSE:CIPLA) Using Too Much Debt?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Jan 26
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Jan 08
Getting In Cheap On Cipla Limited (NSE:CIPLA) Is Unlikely

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Nov 15
Is Cipla (NSE:CIPLA) Using Too Much Debt?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Oct 05
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Aug 04
Does Cipla (NSE:CIPLA) Have A Healthy Balance Sheet?

Is Cipla (NSE:CIPLA) A Risky Investment?

Mar 24
Is Cipla (NSE:CIPLA) A Risky Investment?

A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Mar 06
A Look At The Fair Value Of Cipla Limited (NSE:CIPLA)

Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Dec 11
Cipla (NSE:CIPLA) Has A Pretty Healthy Balance Sheet

Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Aug 19
Estimating The Fair Value Of Cipla Limited (NSE:CIPLA)

Cipla (NSE:CIPLA) Will Pay A Dividend Of ₹5.00

Jul 30
Cipla (NSE:CIPLA) Will Pay A Dividend Of ₹5.00

Cipla (NSE:CIPLA) Could Easily Take On More Debt

Jul 14
Cipla (NSE:CIPLA) Could Easily Take On More Debt

If EPS Growth Is Important To You, Cipla (NSE:CIPLA) Presents An Opportunity

Jul 01
If EPS Growth Is Important To You, Cipla (NSE:CIPLA) Presents An Opportunity

Cipla Limited (NSE:CIPLA) Shares Could Be 34% Above Their Intrinsic Value Estimate

Apr 30
Cipla Limited (NSE:CIPLA) Shares Could Be 34% Above Their Intrinsic Value Estimate

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Mar 23
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Dec 18
Do Cipla's (NSE:CIPLA) Earnings Warrant Your Attention?

Calculating The Fair Value Of Cipla Limited (NSE:CIPLA)

Dec 05
Calculating The Fair Value Of Cipla Limited (NSE:CIPLA)

Is Cipla (NSE:CIPLA) Using Too Much Debt?

Oct 27
Is Cipla (NSE:CIPLA) Using Too Much Debt?

If You Like EPS Growth Then Check Out Cipla (NSE:CIPLA) Before It's Too Late

Sep 16
If You Like EPS Growth Then Check Out Cipla (NSE:CIPLA) Before It's Too Late

Cipla Limited (NSE:CIPLA) Shares Could Be 23% Above Their Intrinsic Value Estimate

Aug 31
Cipla Limited (NSE:CIPLA) Shares Could Be 23% Above Their Intrinsic Value Estimate

It's Unlikely That Cipla Limited's (NSE:CIPLA) CEO Will See A Huge Pay Rise This Year

Aug 18
It's Unlikely That Cipla Limited's (NSE:CIPLA) CEO Will See A Huge Pay Rise This Year

수익 및 비용 분석

Cipla 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

NSEI:CIPLA 수익, 비용 및 수입 (INR Millions )
날짜수익수익G+A 비용R&D 비용
31 Mar 24254,46641,21643,1000
31 Dec 23251,16337,08253,7570
30 Sep 23243,40734,53252,5630
30 Jun 23235,10831,11251,2600
31 Mar 23225,59328,01950,1510
31 Dec 22222,18726,38348,9470
30 Sep 22218,87425,66048,1840
30 Jun 22216,10524,88435,9840
31 Mar 22217,07825,16846,6690
31 Dec 21210,71825,68143,2850
30 Sep 21207,61625,87643,0040
30 Jun 21202,80125,41742,4350
31 Mar 21191,20524,04941,2810
31 Dec 20188,77922,37440,4320
30 Sep 20180,80218,40339,4440
30 Jun 20174,37716,46238,8510
31 Mar 20170,80515,46538,6940
31 Dec 19171,20616,67838,6080
30 Sep 19167,57216,48938,3310
30 Jun 19163,73315,54637,8370
31 Mar 19163,23215,27737,4150
31 Dec 18155,22413,39135,6830
30 Sep 18154,28714,07435,0780
30 Jun 18154,99214,53034,5640
31 Mar 18151,05314,10534,1510
31 Dec 17147,61811,70132,9730
30 Sep 17144,95111,44432,7300
30 Jun 17141,63710,76232,8750
31 Mar 17143,34010,06433,0110
31 Dec 16142,50911,21331,5540
30 Sep 16137,54710,07131,0120
30 Jun 16134,33512,21930,0890
31 Mar 16135,48013,60029,2580
31 Dec 15135,04416,84739,0281,120
30 Sep 15131,63316,69438,2201,120
30 Jun 15124,78215,36837,0961,120
31 Mar 15113,45411,80823,5490
31 Dec 14106,19511,81832,1561,058
30 Sep 14105,62711,38331,3331,058
30 Jun 14104,16411,97630,2241,058
31 Mar 14101,73413,88429,5461,058
31 Dec 1394,33014,04225,122432
30 Sep 1389,50914,60223,641432
30 Jun 1386,54815,90122,631432

양질의 수익: CIPLA 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: CIPLA 의 현재 순이익 이익률 (16.2%) 작년보다 높습니다 (12.4%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: CIPLA 의 수입은 지난 5년 동안 매년 18.4% 씩 증가했습니다.

성장 가속화: 지난 1년간 CIPLA 의 수익 증가율( 47.1% )은 연간 평균( 18.4% 초과합니다. ).

수익 대 산업: 지난 1년간 CIPLA 수익 증가율( 47.1% )은 Pharmaceuticals 업계 18% 초과했습니다.

자기자본 수익률

높은 ROE: CIPLA 의 자본 수익률( 15.5% )은 낮음으로 간주됩니다.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y